What are you looking for today ?
It is with deep sadness that we learned of the passing of our former spokesperson, Mr. Raymond Bouchard. For over 20 years, he devoted himself generously, passionately, and kindly to our organization, actively contributing to the support of people living with diabetes. Through his voice, presence, and unwavering dedication, he played a pivotal role in…
After nearly 20 years with the organization, Sylvie Lauzon, President and CEO, has retired after a well-deserved career. We sincerely thank her for her exemplary commitment and for everything she has helped build over the years. In a spirit of transition, Susana Lazaro takes the helm of Diabete sQuébec as President and CEO. She begins…
The offices of Diabetes Québec will be closed for the holiday season from December 24, 2025, to January 2, 2026. We will reopen on Monday, January 5, 2026. Unfortunately, it will not be possible to reach us by phone or email during this period. If you are a participant in the Support Program, please consult…
Abbott has issued a recall for their new continuous glucose monitoring device, the FreeStyle Libre 3 Plus. Certain FreeStyle Libre 3 Plus sensors may provide inaccurate low-glucose readings. Other FreeStyle Libre products are not affected by this issue. Potential Danger If undetected, an incorrect low-glucose reading over an extended period can lead to inappropriate treatment…
The Régie de l’assurance maladie du Québec (RAMQ) has issued a notice informing us that the Precision Xtra (Ketone) product listed on the List of Medications is currently out of stock. During the stock shortage, RAMQ will temporarily reimburse you for the actual acquisition cost of the following product, effective since November 18, 2025: FreeStyle…
People using intensive insulin therapy—that is, at least three insulin injections per day, regardless of diabetes type—now have access to coverage for continuous glucose monitoring (CGM) devices from two different companies. The Régie de l’assurance maladie du Québec (RAMQ) has expanded reimbursement criteria for the Dexcom G6MD and G7MD to include people living with type…
Reflecting the achievements of Diabetes Québec during the fiscal year ending June 30, the Diabetes Québec Impact Report is now available for consultation! Diabetes Québec thanks Ms. Patricia Beaulieu, who has been living with type 1 diabetes for over 30 years, for proudly agreeing to appear on the cover alongside her partner, Mathieu. Enjoy the…
We regret to inform you that there will be no scholarship or grant competition in 2026. We invite you to visit our website in October 2026 for the opening of the 2027 competition.
Dr. Rémi Rabasa-Lhoret, physician, researcher, esteemed professor, and President of the CPDQ of Diabetes Québec, has been awarded the Diabetes Canada Lifetime Achievement Award 2025, the highest Canadian distinction in the field of diabetes.
Interview with Dr. Rémi Rabasa-Lhoret, President of the CPDQ of Diabetes Québec